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CBPP is a severe respiratory disease of cattle and buffalo caused
by Mycoplasma mycoides subsp. mycoides biotype Small Colony
(MmmSC). The agent of CBPP was recently isolated from goats at
different times and places, even in areas free of CBPP. Thereby,
goats should be considered a putative MmmSC reservoir. No test
has been proposed so far for surveillance of CBPP in goats.
Furthermore, serological tests might be seriously hampered by a
common caprine infection due to M. mycoides subsp. capri (Mmc),
a subspecies that is antigenically very close to MmmSC.
42% of mycoplasmas isolated in goats are Mmc*
France is CBPP-free
Aim: This study was conducted to assess whether the competitive ELISA currently recommended by the OIE for CBPP screening 
at the herd level in cattle was suitable for caprine monitoring notably in terms of specificity. 
Background: Surveillance of Contagious bovine pleuropneumonia (CBPP) in a currently free country, a complex challenge.
France is CA-infected
Methods and Results1:  cELISA serology as a herd test
325 sera were collected from 11 goat herds (~30 sera/herd). Six
herds were considered Mmc-infected (isolation of Mmc strains from
bulk milk tanks) while 5 other herds were considered non-infected.
Competition ELISA titers were measured as indicated by the
supplier (Institut Pourquier/CIRAD). cELISA titers were comparable
within the 2 populations and were altogether normally distributed
with a mean of 24+/-12% (Fig.1A). The resulting bell curve was
below the cut-off established for bovine sera positivity (i.e. inhibition
>50% ).
In comparison, bovine sera from a randomly chosen population of
309 herds (~2 sera/herd) gave cELISA results very similar to that
obtained with goats (with a mean of 29+/-10%) (Fig.1B). All bovine
sera -but one doubtful- were negative, as expected.
Methods & Results 2: Description of a 3F3+ Mmc strain
Strain #14690 was isolated in 2006 in France from the joint of a
goat with arthritis. It reacted with the 3F3 monoclonal antibody
specific to MmmSC (and targeted by the cCBPP ELISA kit) but
was identified (sequence analysis) as a Mmc.
Such Mmc strains are of rare occurrence and only 2 were isolated
in France between 2003 and 2008 out of 550 screened Mmc
strains (0.4%).*
The 3F3-coding sequence (87 nt) was amplified with specific
primers and compared between several strains (11 MmmSC and
25 Mmc). The region is highly conserved within the MmmSC
taxon but very variable within the Mmc subspecies (multiple, long
branches in the resulting phylogenic tree, Fig.2). Strain #14690
shows 6/87 nucleotides polymorphism when compared to the
consensus sequence of MmmSC resulting in only 2 amino acid
differences (D<->E and N<->D).
MmmSC
A              B
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Conclusions
The commercially available cELISA can be used in a CBPP-free 
context for both goat and cattle monitoring.
In goats, the test sensitivity has yet to be assessed. In general, its
specificity is not hampered by circulation of Mmc strains and the falsely
positive reactions induced by 3F3+ Mmc strains are poorly probable in
field conditions since occurrence of 3F3+ Mmc strains is random (due to
genetic polymorphisms) and unsual (0.4%)*.
In cattle, presence of Mmc strains in clinical specimens is rare (0.4%)*.
Mmc circulation in a non-clinical context has yet to be documented but
should not – by analogy with the situation in goats- influence the overall
cELISA test specificity.
* Data from the French network VIGIMYC between 2003-2008.
# 14690
Fig.1: cELISA results (distribution of sera as a function of the % of inhibition)
Fig.2:  Phylogenic tree constructed by the Neighbour Joining method
(1000 iterations) on the 87 bp 3F3 coding sequence. The Mmc
strains are grouped under the « orange » boxes 
Methods & Results 3: cELISA analysis of the experimentally
produced antisera against Mmc#14690
Goat sera produced by subcutaneous inoculation of Mmc #14690 (2
ml x ~108 cfu/ml) were analyzed by CBPP-cELISA .
A significant seroconversion - comparable to that obtained in goats
after inoculation of a MmmSC pathogenic strain and above the
positivity threshold for cattle - was evidenced for 2 goats (Fig.3).
Fig.3: cELISA follow-up of goats sera after inoculation of Mmc#14690
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